Complement activation by drug carriers and particulate pharmaceuticals: Principles, challenges and opportunities

Area of Science:

• Immunology
• Nanomedicine
• Pharmaceutical Sciences

Background:

• The complement system plays vital roles in host defense and homeostasis.
• Particulate pharmaceutical formulations, including nano- and micro-particles, can activate the complement cascade upon administration.
• This activation has significant implications for drug delivery and therapeutic outcomes.

Purpose of the Study:

• To review the mechanistic processes of complement activation by pre-clinical and clinical particles.
• To identify current challenges and opportunities in nanomedicine-complement research.
• To suggest future research directions at the nanomedicine-complement interface.

Main Methods:

• Review of current literature on complement activation by pharmaceutical particles.
• Analysis of mechanistic pathways involved in particle-induced complement cascade.
• Examination of pre-clinical and clinical data regarding particle-complement interactions.

Main Results:

• Complement activation can lead to formulation destabilization and opsonization, affecting particle performance.
• The effects of complement activation can be beneficial (prophylactic) or deleterious (disease progression).
• Particle design must consider complement activation properties in relation to administration route, dosing, and therapeutic goals.

Conclusions:

• Careful consideration of complement activation is essential for the rational design of particulate medicines.
• Further research is needed to fully elucidate and leverage the nanomedicine-complement interface for therapeutic benefit.
• Understanding these interactions will optimize the safety and efficacy of nanomedicines.